In order to evaluate whether MDSCs belong to the tumor clone or normal residual cells, in 3 patients we analyzed BCR/ABL expression in both CD11b+CD33+CD14-HLADR- and CD14+HLADR- subpopulation cells and all samples showed the oncoprotein expression in both the two subsets (data not shown). This evidence concerns the gene BCR and neoplasm.